Anticancer Activity of Cisplatin and Related Complexes

  • Andrew Gelasco
  • Stephen J. Lippard
Chapter
Part of the Topics in Biological Inorganic Chemistry book series (TBIC, volume 1)

Abstract

Cisplatin is a simple inorganic compound which has proved to be a very effective anticancer drug, especially against testicular tumors. The compound has therapeutic limitations based primarily on toxic side effects and acquired resistance. The mechanism of action of cisplatin is under intense study in order to understand the chemical basis for these limitations and to develop in a rational manner a new generation of platinum-based antitumor drugs. These studies have led to the discovery of new classes of anticancer platinum compounds, including some which utilize both mononuclear and dinuclear Pt(II) and trans-Pt(IV)geometries. High-resolution structures of cisplatin and derivatives bound to duplex DNA have been determined both by X-ray crystallography and by NMR solution methods. Also noteworthy is the discovery of DNA-binding proteins that specifically recognize cisplatinmodified DNA. The contributions of each of these different areas of study towards an understanding of the molecular mechanism of the anticancer activity of cisplatin are discussed.

Keywords

Cisplatin Anticancer DNA HMG-domain proteins Platinum drugs 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pil P, Lippard SJ (1997) Cisplatin and related drugs. In: Bertino JR (ed) Encyclopedia of cancer. Academic Press, San Diego, p 392Google Scholar
  2. 2.
    Loehrer PJ, Einhorn LH (1984) Ann Inter Med 100: 704Google Scholar
  3. 3.
    Pinedo HM, Schornagel JH (eds) (1996) Platinum and other metal coordination compounds in cancer chemotherapy. Plenum Press, New YorkGoogle Scholar
  4. 4.
    Chu G (1994) J Biol Chem 269: 787PubMedGoogle Scholar
  5. 5.
    Rosenberg B, Camp L, Krigas T (1965) Nature 205: 698PubMedGoogle Scholar
  6. 6.
    Rosenberg B, Camp L, Trosko JE, Mansour VH (1969) Nature 222: 385PubMedGoogle Scholar
  7. 7.
    Vijgh WJF (1991) Clinical Pharmacokinetics 21: 242PubMedGoogle Scholar
  8. 8.
    Kelland LR, Abel G, McKeage MJ, Jones M, Goddard PM, Valenti M, Morrer BA, Harrap KR (1993) Cancer Research 53: 2581PubMedGoogle Scholar
  9. 9.
    Hartwig JF, Lippard SJ (1992) J Am Chem Soc 114: 5646Google Scholar
  10. 10.
    Fichtinger-Schepman AMJ, van der Veer JL, den Hartog JHJ, Lohman PHM, Reedijk J (1985) Biochemistry 24: 707PubMedGoogle Scholar
  11. 11.
    Fichtinger-Schepman AMJ, Dijt FT, de Jong WH, van Oosterom AT, Berends F (1988) In vivo cis-diamminedichloroplatinum(II)-DNA adduct formation and removal as measured with immunochemical techniques. In: Nicolini M (ed) Platinum and other metal coordination compounds in cancer chemotherapy. Nijhoff, Boston, p 33Google Scholar
  12. 12.
    Sherman SE, Gibson D, Wang AH-J, Lippard SJ (1985) Science 230: 412PubMedGoogle Scholar
  13. 13.
    den Hartog JHJ, Altona C, Chottard J-C, Girault J-P, Lallemand J-Y, de Leeuw FAAM, Marcelis ATM, Reedijk J (1982) Nucleic Acids Res 10: 4715Google Scholar
  14. 14.
    Admiraal G, van der Veer JL, de Graaff RAG, den Hartog JHJ, Reedijk J (1987) J Am Chem Soc 109: 592Google Scholar
  15. 15.
    den Hartog JHJ, Altona C, van Boom JH, van der Marel GA, Haasnoot CAG, Reedijk J (1985) J Biomol Struct Dynam 2: 1137Google Scholar
  16. 16.
    Herman F, Kozelka J, Stoven V, Guittet E, Girault J-P, Huynh-Dinh T, Igolen J, Lallemand J-Y, Chottard J-C (1990) Eur J Biochem 194: 119PubMedGoogle Scholar
  17. 17.
    Rice JA, Crothers DM, Pinto AL, Lippard SJ (1988) Proc Natl Acad Sci USA 85: 4158PubMedGoogle Scholar
  18. 18.
    Bellon SF, Lippard SJ (1990) Biophys Chem 35: 179PubMedGoogle Scholar
  19. 19.
    Bellon SF, Coleman JH, Lippard SJ (1991) Biochemistry 30: 8026PubMedGoogle Scholar
  20. 20.
    Sanderson BJS, Ferguson LR, Denny WA (1996) Mutat Res-Fundam Mol Mech Muta-gen 355: 59Google Scholar
  21. 21.
    Gately DP, Howell SB (1993) Brit J Cancer 67: 1171PubMedGoogle Scholar
  22. 22.
    Matsumoto T, Endoh K, Akamatsu K, Kamisango K, Mitsui H, Koizumi K, Morikawa K, Koizumi M, Matsuno T (1991) Brit J Cancer 64: 41PubMedGoogle Scholar
  23. 23.
    Holford J, Raynaud F, Murrer BA, Grimaldi K, Hartley JA, Abrams M, Kelland LR (1998) Anti-Cancer Drug Des 13: 1Google Scholar
  24. 24.
    Holford J, Sharp SY, Murrer BA, Abrams M, Kelland LR (1998) Brit J Cancer 77: 366PubMedGoogle Scholar
  25. 25.
    Kelland LR (1993) Grit Rev Oncol-Hematol 15: 191Google Scholar
  26. 26.
    Bleiberg H (1998) Brit J Cancer 77 (S4): 1PubMedGoogle Scholar
  27. 27.
    Cvitkovic E (1998) Brit J Cancer 77 (S4): 8PubMedGoogle Scholar
  28. 28.
    McKeage MJ, Abel G, Kelland LR, Harrap KP (1994) Brit J Cancer 69: 1PubMedGoogle Scholar
  29. 29.
    Mellish KJ, Kelland LR (1994) Cancer Res 54: 6194PubMedGoogle Scholar
  30. 30.
    Novakova O, Vrana O, Kiseleva VI, Brabec V (1995) Eur J Biochem 228: 616PubMedGoogle Scholar
  31. 31.
    McKeage MJ, Mistry P, Ward J, Boxall FE, Loh S, O’Neill C, Ellis P, Kelland LR, Morgan SE, Murrer BA, Santabarbara P, Harrap KR, Judson IR (1995) Cancer Chemother Pharmaco 136:451Google Scholar
  32. 32.
    Harrap KR, Murrer BA, Giandomenico C, Morgan SE, Kelland LR, Jones M, Goddard PM, Schurig J (1991) Ammine/amine platinum(IV) dicarboxylates: a novel class of complexes which circumvent intrinsic cisplatin resistance. In: Howell SB (ed) Platinum and other metal coordination complexes in cancer chemotherapy. Plenum Press, New York, p 391Google Scholar
  33. 33.
    Sandman KS, Fuhrmann P, Lippard SJ (1998) J Biol Inorg Chem 3: 74Google Scholar
  34. 34.
    Toney JH, Donahue BA, Kellett PJ, Bruhn SL, Essigmann JM, Lippard SJ (1989) Proc Natl Acad Sci USA 86: 8328PubMedGoogle Scholar
  35. 35.
    Whitehead JP, Lippard SJ (1996) Proteins that bind to and mediate the biological activity of platinum anticancer drug-DNA adducts. In: Sigel A, Sigel H (eds) Metal ions in biological systems. Marcel Dekker Inc, New York, p 687Google Scholar
  36. 36.
    Pil PM, Lippard SJ (1992) Science 256: 234PubMedGoogle Scholar
  37. 37.
    Sandman KE, Lippard SJ (1999) Methods for sreening the potential antitumor activity of platinum compounds in combinatorial libraries. In: Lippert B (ed) Thirty years of cisplatin: chemistry and biochemistry of a leading anticancer drug (in press)Google Scholar
  38. 38.
    Kelland LR, Barnard CFJ, Mellish KJ, Jones M, Goddard PM, Valenti M, Bryant A, Murrer BA, Harrap KR (1994) Cancer Res 54: 5618PubMedGoogle Scholar
  39. 39.
    Kelland LR, Barnard CFJ, Evans IG, Murrer BA, Theobald BRC, Wyer SB, Goddard PM, Jones M, Valenti M, Bryant A, Rogers PM, Harrap KR (1995) J Med Chem 38: 3016PubMedGoogle Scholar
  40. 40.
    Kraker AJ, Hoeschele JD, Elliott WL, Showalter HDH, Sercel AD, Farrell NP (1992) J Med Chem 35: 4526PubMedGoogle Scholar
  41. 41.
    Farrell N (1993) Cancer Invest 11: 578PubMedGoogle Scholar
  42. 42.
    Zou Y, van Houten B, Farrell N (1994) Biochemistry 33: 5404PubMedGoogle Scholar
  43. 43.
    Kasparkova J, Mellish KJ, Qu Y, Brabec V, Farrell N (1996) Biochemistry 35: 16705PubMedGoogle Scholar
  44. 44.
    Zaludova R, Zakovska A, Kasparkova J, Balcarova Z, Kleinwachter V, Vrana O, Farrell N, Brabec V (1997) Eur J Biochem 246: 508PubMedGoogle Scholar
  45. 45.
    Sherman SE, Gibson D, Wang AH-J, Lippard SJ (1988) J Am Chem Soc 110: 7368Google Scholar
  46. 46.
    Takahara PM, Rosenzweig AC, Frederick CA, Lippard SJ (1995) Nature 377: 649PubMedGoogle Scholar
  47. 47.
    Yang D, van Boom SSGE, Reedijk J, van Boom JH, Wang AH-J (1995) Biochemistry 34: 1 2912Google Scholar
  48. 48.
    Gelasco A, Lippard SJ (1998) Biochemistry 37: 9230PubMedGoogle Scholar
  49. 49.
    Dunham SU, Dunham SU, Turner CJ, Lippard SJ (1998) J Am Chem Soc 120: 5395Google Scholar
  50. 50.
    Johnson NP, Hoeschele JD, Rahn RO (1980) Chem-Biol Interactions 30: 151Google Scholar
  51. 51.
    Bancroft DP, Lepre CA, Lippard SJ (1990) J Am Chem Soc 112: 6860Google Scholar
  52. 52.
    Orton DM, Gretton VA, Green M (1993) Inorg Chim Acta 204: 265Google Scholar
  53. 53.
    Fichtinger-Schepman AMJ, Lohman PHM, Reedijk J (1982) Nucleic Acids Res 10:5345Google Scholar
  54. 54.
    Elmroth SKC, Lippard SJ (1994) J Am Chem Soc 116: 3633Google Scholar
  55. 55.
    Hambley TW (1997) Coord Chem Rev 166: 181Google Scholar
  56. 56.
    Bloemink MJ, Reedijk J (1996) Cisplatin and derived anticancer drugs: mechanism and current status of DNA binding. In: Sigel A, Sigel H (eds) Metal ions in biological systems. Marcel Dekker Inc, New York, p 641Google Scholar
  57. 57.
    Barnham KJ, Berners-Price SJ, Frenkiel TA, Frey U, Sadler PJ (1995) Angew Chem Int Ed Engl 34: 1874Google Scholar
  58. 58.
    Berners-Price SJ, Barnham KJ, Frey U, Sadler PJ (1996) Chem Eur J 2: 1283Google Scholar
  59. 59.
    Dewan J (1984) J Am Chem Soc 106: 7239Google Scholar
  60. 60.
    Hongo A, Seki S, Akiyama K, Kudo T (1994) Int J Biochem 26: 1009PubMedGoogle Scholar
  61. 61.
    Cohen GL, Bauer WR, Barton JK, Lippard SJ (1979) Science 203: 1014PubMedGoogle Scholar
  62. 62.
    Blommaert FA, van Dijk-Knijnenburg HCM, Dijt FJ, den Engelse L, Baan RA, Berends F, Fichtinger-Schepman AMJ (1995) Biochemistry 34: 8474PubMedGoogle Scholar
  63. 63.
    Fichtinger-Schepman AMJ, van Dijk-Knijnenburg HCM, van der Velde-Visser SD, Be-rends F, Baan RA (1995) Carcinogenesis 16: 2447PubMedGoogle Scholar
  64. 64.
    Salazar I, Tarrago-Litvak L, Gil L, Litvak S (1982) FEBS Lett 138: 45PubMedGoogle Scholar
  65. 65.
    Olivero OA, Semino C, Kassim A, Lopez-Larraza DM, Poirier MC (1995) Mutat Res Lett 346: 221Google Scholar
  66. 66.
    Olivero OA, Chang PK, Lopez-Larraza DM, Semino-Mora MC, Poirier MC (1997) Mu-tat Res Genet Toxicol Environ Mutagen 391: 79Google Scholar
  67. 67.
    Counter CM (1996) Mutat Res Reviews in Genetic Toxicology 366: 45Google Scholar
  68. 68.
    Counter CM, Hirte HW, Bacchetti S, Harley CB (1994) Proc Natl Acad Sci USA 91: 2900PubMedGoogle Scholar
  69. 69.
    Ishibashi T, Lippard SJ (1998) Proc Natl Acad Sci USA 95: 4219PubMedGoogle Scholar
  70. 70.
    Takahara PM, Frederick CA, Lippard SJ (1996) J Am Chem Soc 118: 12309Google Scholar
  71. 71.
    Huang H, Zhu L, Reid BR, Drobny GP, Hopkins PB (1995) Science 270: 1842PubMedGoogle Scholar
  72. 72.
    Paquet F, Perez C, Leng M, Lancelot G, Malinge J-M (1996) J Biomol Struct Dyn 14: 67PubMedGoogle Scholar
  73. 73.
    Kraulis PJ (1991) J Appl Cryst 24: 946Google Scholar
  74. 74.
    Sundquist WI, Lippard SJ, Stollar BD (1986) Biochemistry 25: 1520PubMedGoogle Scholar
  75. 75.
    van Boom SSGE, Yang D, Reedijk J, van der Marel GA, Wang AH-J (1996) J Biomol Struct Dyn 13: 989PubMedGoogle Scholar
  76. 76.
    Dunham SU, Lippard SJ (1995) J Am Chem Soc 117: 10702Google Scholar
  77. 77.
    Lemaire M-A, Schwartz A, Rahmouni AR, Leng M (1991) Proc Natl Acad Sci USA 88: 1982PubMedGoogle Scholar
  78. 78.
    Sip M, Schwartz A, Vovelle F, Ptak M, Leng M (1992) Biochemistry 31: 2508PubMedGoogle Scholar
  79. 79.
    Malinge J-M, Pérez C, Leng M (1994) Nucleic Acids Res 22: 3834PubMedGoogle Scholar
  80. 80.
    Wang AH-J, Quigley GJ, Kolpak FJ, Crawford JL, van Boom JH, van der Marel G, Rich A (1979) Nature 282: 680PubMedGoogle Scholar
  81. 81.
    Rappé AK, Casewit CJ (1997) Molecular mechanics across chemistry, 1st edn. University Science Books, Sausalito, CAGoogle Scholar
  82. 82.
    den Hartog JHJ, Altona C, van der Elst H, van der Marel GA, Reedijk J (1985) Inorg Chem 24: 983Google Scholar
  83. 83.
    van Garderen CJ, van Houte LPA (1994) Eur J Biochem 225: 1169PubMedGoogle Scholar
  84. 84.
    Lepre CA, Chassot L, Costello CE, Lippard SJ (1990) Biochemistry 29: 811PubMedGoogle Scholar
  85. 85.
    Yang D, van Boom SSGE, Reedijk J, van Boom JH, Farrell N, Wang AH-J (1995) Nature Struct Biol 2: 577PubMedGoogle Scholar
  86. 86.
    Yang D, Wang AH-J (1996) Prog Biophys Molec Biol 66: 81Google Scholar
  87. 87.
    Ferrari S, Harley VR, Pontiggia A, Goodfellow PN, Lovell-Badge R, Bianchi ME (1992) EMBO J 11: 4497PubMedGoogle Scholar
  88. 88.
    Comess KM, Costello CE, Lippard SJ (1990) Biochemistry 29: 2102Google Scholar
  89. 89.
    Dalbiès R, Payet D, Leng M (1994) Proc Natl Acad Sci USA 91: 8147PubMedGoogle Scholar
  90. 90.
    Dalbiès R, Boudvillain M, Leng M (1995) Nucleic Acids Res 23: 949PubMedGoogle Scholar
  91. 91.
    Pérez C, Leng M, Malinge J-M (1997) Nucleic Acids Res 25: 896PubMedGoogle Scholar
  92. 92.
    Gelasco A, Dunham SU, Lippard SI unpublished resultsGoogle Scholar
  93. 93.
    Berners-Price SJ, Corazza A, Guo Z, Barnham KJ, Sadler PI, Ohyama Y, Leng M, Locker D (1997) Eur J Biochem 243: 782PubMedGoogle Scholar
  94. 94.
    Hardman CH, Broadhurst RW, Raine ARC, Grasser KD, Thomas JO, Laue ED (1995) Biochemistry 34: 16596PubMedGoogle Scholar
  95. 95.
    Read CM, Cary PD, Crane-Robinson C, Driscoll PC, Norman DG (1993) Nucleic Acids Res 21: 3427PubMedGoogle Scholar
  96. 96.
    Weir HM, Kraulis PI, Hill CS, Raine ARC, Laue ED, Thomas JO (1993) EMBO J 12: 1311PubMedGoogle Scholar
  97. 97.
    Chow CS, Barnes CM, Lippard SJ (1995) Biochemistry 34: 2956PubMedGoogle Scholar
  98. 98.
    Love II, Li X, Case DA, Giese K, Grosschedl R, Wright PE (1995) Nature 376: 791PubMedGoogle Scholar
  99. 99.
    Werner MH, Huth JR, Gronenborn AM, Clore GM (1995) Cell 81: 705PubMedGoogle Scholar
  100. 100.
    Zambie DB, Lippard SI (1999) The response of Cellular proteins to Cisplatin-damaged DNA. In: Lippert B (ed) Thirty tears of cisplatin: chemistry and biochemistry of a leading anticancer drug (in press)Google Scholar
  101. 101.
    Bruhn SL, Toney JH, Lippard SJ (1990) Prog Inorg Chem 38: 477Google Scholar
  102. 102.
    Bruhn SL, Pil PM, Essigmann JM, Housman DE, Lippard SI (1992) Proc Natl Acad Sci USA 89: 2307PubMedGoogle Scholar
  103. 103.
    Sinclair AH, Berta P, Palmer MS, Hawkins JR, Griffiths BL, Smith MJ, Foster JW, Frischauf A-M, Lovell-Badge R, Goodfellow PN (1990) Nature 346: 240PubMedGoogle Scholar
  104. 104.
    Travis A, Amsterdam A, Belanger C, Grosschedl R (1991) Genes Dev 5: 880PubMedGoogle Scholar
  105. 105.
    Parisi MA, Clayton DA (1991) Science 252: 965PubMedGoogle Scholar
  106. 106.
    Hughes EN, Engelsberg BN, Billings PC (1992) J Biol Chem 267: 13520PubMedGoogle Scholar
  107. 107.
    Pil PM, Chow CS, Lippard SI (1993) Proc Natl Acad Sci U S A 90: 9465PubMedGoogle Scholar
  108. 108.
    Dyer MA, Hayes PI, Baron MH (1998) Mol Cell Bio 18: 2617Google Scholar
  109. 109.
    Chow CS, Whitehead JP, Lippard SI (1994) Biochemistry 33: 15124PubMedGoogle Scholar
  110. 110.
    Bianchi ME, Beltrame M, Falciola L (1992) In: Eckstein F, Lilley DMJ (eds) Nucleic acids and molecular biology. Springer-Verlag, Berlin Heidelberg, p 112Google Scholar
  111. 111.
    Grosschedl R, Giese K, Pagel J (1994) Trends Genet 10: 94PubMedGoogle Scholar
  112. 112.
    McA Nulty MM, Whitehead JP, Lippard SI (1996) Biochemistry 35: 6089Google Scholar
  113. 113.
    Fisher RP, Lisowsky T, Parisi MA, Clayton DA (1992) J Biol Chem 267: 3358PubMedGoogle Scholar
  114. 114.
    Ohndorf U-M, Whitehead JP, Raju NL, Lippard SI (1997) Biochemistry 36: 14807PubMedGoogle Scholar
  115. 115.
    Trimmer EE, Zamble DB, Lippard SI, Essigmann 1M (1998) Biochemistry 37: 352PubMedGoogle Scholar
  116. 116.
    Dunham SU, Lippard SI (1997) Biochemistry 35: 11428Google Scholar
  117. 117.
    Payet D, Travers A (1997) J Mol Biol 266: 66PubMedGoogle Scholar
  118. 118.
    Kane SA, Lippard H (1996) Biochemistry 35: 2180PubMedGoogle Scholar
  119. 119.
    Read CM, Cary PD, Preston NS, Lnenicek-Allen M, Crane-Robinson C (1994) EMBO J 13: 5639PubMedGoogle Scholar
  120. 120.
    Zamble DB, Lippard SJ (1995) Trends Biochem Sci 20: 435PubMedGoogle Scholar
  121. 121.
    Huang J-C, Zamble DB, Reardon JT, Lippard SI, Sancar A (1994) Proc Natl Acad Sci USA 91: 10394PubMedGoogle Scholar
  122. 122.
    Zambie DB, Mu D, Reardon IT, Sancar A, Lippard SI (1996) Biochemistry 35: 10004Google Scholar
  123. 123.
    Brown SJ, Kellett PJ, Lippard SI (1993) Science 261: 603PubMedGoogle Scholar
  124. 124.
    McA’Nulty MM, Lippard SI (1996) Mutat Res-DNA Repair 362: 75PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • Andrew Gelasco
    • 1
  • Stephen J. Lippard
    • 1
  1. 1.Department of ChemistryMassachusetts Institute of TechnologyCambridgeUSA

Personalised recommendations